Table 1.
Description of a cohort of UM patients used in the study.
| Omics data | Platform | Description |
|---|---|---|
| mRNA | mRNA sequencing | A continuous matrix whose columns (the number of samples) are 80 samples and rows (the number of genes) are 20,440 genes |
| CNA | Affymetrix SNP6 Whole-exome sequencing |
A discrete matrix whose columns (the number of samples) are 80 samples and rows (the number of genes) are 24,776 genes. There are four copy-number levels indicated for each gene, namely, −2, −1, 1, and 2. Two levels presented with minus value (i.e., −2, −1) show the loss level of copy-number compared with the two positive values (i.e., 1, 2) expressing the additional copies degree. For the 0 level, the gene is located in the diploid chromosomal region. |
| MET | Illumina Infinium HumanMethylation 450 platform | A continuous matrix whose columns (the number of samples) are 80 samples and rows (the number of genes) are 15,477 genes |
| Clinical data | Samples: 80 Overall survival (OS) status was defined as vital status (dead or alive), whereas OS time was identified as the time to UM death or last follow-up (unit: day). The follow-up time OS was truncated to 2,600 days. |